Search

everythinglearnresearchcommunity

for

Search:↓

A specific gene variant causes severe skin issues and increases infection risk, requiring careful medical monitoring.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Metformin helps manage PCOS by improving fertility and is safe for pregnancy, especially when combined with certain treatments.

Most skin care products are safe during pregnancy, but avoid hydroquinone and tretinoin.

Microneedles could revolutionize pediatric medicine by offering painless drug delivery, but more development is needed.

A new method effectively predicts estrogen-related health effects for early screening.

Combining minoxidil and plant extracts improved hair growth in a boy with a rare genetic disorder.

Applying DMG-Na to the skin increases blood flow and may help with skin conditions.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Platelet Rich Plasma (PRP) injections can improve hair count, thickness, and strength in people with androgenic alopecia.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Ashwagandha may improve hormone levels and reduce hair loss in non-classical adrenal hyperplasia.

Exposure to the hair loss drug finasteride during pregnancy can cause genital anomalies in male babies, but not in female babies. It's best to avoid this drug in women who could potentially become pregnant.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Spironolactone is effective for treating female hair loss, with new treatments like clascoterone showing promise.

Zinc levels don't significantly affect hair loss, so testing for zinc isn't necessary.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Early diagnosis and aggressive treatment are crucial for managing SLE-related pancreatitis in children.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Skin pigmentation varies due to genetics, UV exposure, and drugs, with treatments available but requiring medical advice.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Keratin 16 delays skin maturation and affects skin and hair development in mice.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

PRP helps tissue repair but lacks standard preparation methods.

Scaffold-based strategies show promise for regenerating hair follicles and teeth but need more research for clinical use.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.